(Q35097404)

6 August 2017

Retention of the arginine allele in codon 72 of the p53 gene correlates with poor apoptosis in head and neck cancer (English)

1 reference

6 August 2017

1 reference

1 reference

head and neck carcinoma

1 reference

inferred from title

author

Regine Schneider-Stock

1

object named as

Regine Schneider-Stock

0 references

author name string

Regine Schneider-Stock

1

1 reference

6 August 2017

Christian Mawrin

2

1 reference

6 August 2017

Christiane Motsch

3

1 reference

6 August 2017

Carsten Boltze

4

1 reference

6 August 2017

Brigitte Peters

5

1 reference

6 August 2017

Roland Hartig

6

1 reference

6 August 2017

Peter Buhtz

7

1 reference

6 August 2017

Anja Giers

8

1 reference

6 August 2017

Astrid Rohrbeck

9

1 reference

6 August 2017

Bernd Freigang

10

1 reference

6 August 2017

Albert Roessner

11

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

The American Journal of Pathology

6 August 2017

1 reference

6 August 2017

164

1 reference

6 August 2017

1233-1241

1 reference

6 August 2017

4

1 reference

The p53 network in head and neck cancer

6 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615339

Relationship between p53 codon 72 polymorphism and susceptibility to sunburn and skin cancer

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615339

Tissue-specific regulation of Fas/APO-1/CD95 expression by p53.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615339

Tumor suppressor p53 mediates apoptotic cell death triggered by cyclosporin A.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615339

Fas receptor-mediated apoptosis: a clinical application?

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615339

p53 activates the mitochondrial death pathway and apoptosis of ventricular myocytes independent of de novo gene transcription

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615339

p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615339

A common polymorphism acts as an intragenic modifier of mutant p53 behaviour

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615339

Fas and Fas ligand in gut and liver

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615339

Fas ligand-induced apoptosis

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615339

Human and mouse Fas (APO-1/CD95) death receptor genes each contain a p53-responsive element that is activated by p53 mutants unable to induce apoptosis

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615339

Apoptosis, p53, and tumor cell sensitivity to anticancer agents

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615339

Two polymorphic variants of wild-type p53 differ biochemically and biologically

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615339

p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615339

Death receptors: signaling and modulation

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615339

p53 mutations in head and neck cancer: new data and evaluation of mutational spectra

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615339

Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615339

Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615339

p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615339

Expression of apoptosis-related proteins in Barrett's metaplasia-dysplasia-carcinoma sequence: a switch to a more resistant phenotype.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615339

The IARC TP53 database: new online mutation analysis and recommendations to users

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615339

p53 codon 72 polymorphism and its association with bladder cancer

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615339

Alterations in exon 4 of the p53 gene in gastric carcinoma

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615339

The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615339

Genetic polymorphism and cancer susceptibility: fourteenth Sapporo Cancer Seminar.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1615339

P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck: a case-control study

27 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963211-7

Fas ligand is frequently expressed in human pancreatic duct cell carcinoma

7 January 2021

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963211-7

Telomerase activity in head and neck tumors after introduction of wild-type p53, p21, p16, and E2F-1 genes by means of recombinant adenovirus

7 January 2021

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963211-7

7 January 2021

inferred from DOI database lookup

Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15039212

12 December 2020

inferred from PubMed ID database lookup

Preferential retention of codon 72 arginine p53 in squamous cell carcinomas of the vulva occurs in cancers positive and negative for human papillomavirus

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15039212

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1016/S0002-9440(10)63211-7

1 reference

6 August 2017

1 reference

6 August 2017

1 reference